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Abstract
The type III secretion system of the Salmonella flagellum consists of 6 integral membrane proteins: FlhA, FlhB, FliO, FliP, FliQ,
and FliR. However, in some other type III secretion systems, a homologue of FliO is apparently absent, suggesting it has a
specialized role. Deleting the fliO gene from the chromosome of a motile strain of Salmonella resulted in a drastic decrease
of motility. Incubation of the DfliO mutant strain in motility agar, gave rise to pseudorevertants containing extragenic
bypass mutations in FliP at positions R143H or F190L. Using membrane topology prediction programs, and alkaline
phosphatase or GFPuv chimeric protein fusions into the FliO protein, we demonstrated that FliO is bitopic with its N-
terminus in the periplasm and C-terminus in the cytoplasm. Truncation analysis of FliO demonstrated that overexpression of
FliO43–125 or FliO1–95 was able to rescue motility of the DfliO mutant. Further, residue leucine 91 in the cytoplasmic domain
was identified to be important for function. Based on secondary structure prediction, the cytoplasmic domain, FliO43–125,
should contain beta-structure and alpha-helices. FliO43–125-Ala was purified and studied using circular dichroism
spectroscopy; however, this domain was disordered, and its structure was a mixture of beta-sheet and random coil.
Coexpression of full-length FliO with FliP increased expression levels of FliP, but coexpression with the cytoplasmic domain
of FliO did not enhance FliP expression levels. Overexpression of the cytoplasmic domain of FliO further rescued motility of
strains deleted for the fliO gene expressing bypass mutations in FliP. These results suggest FliO maintains FliP stability
through transmembrane domain interaction. The results also demonstrate that the cytoplasmic domain of FliO has
functionality, and it presumably becomes structured while interacting with its binding partners.
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Introduction
For many bacteria, locomotion is possible using the flagellum,
which functions like a helical propeller. It is a highly complex
nanomachine consisting of about 30 different proteins, and it is
organized into three substructures: the basal body, the hook, and
the filament. Export of the components of the flagellum across the
cytoplasmic membrane requires a specialized secretion apparatus
at its base, which shares homology to the type III secretion
apparatus of the bacterial needle used by some Gram-negative
bacteria in pathogenesis [1]. For the flagella systems of Escherichia
coli and Salmonella enterica serovar Typhimurium, the secretion
apparatus is postulated to consist of six integral membrane
proteins: FlhA, FlhB, FliO, FliP, FliQ, and FliR; and three
cytoplasmic proteins: FliH, FliI and FliJ [2,3]. Biochemical and
genetic studies have determined the location of the membrane
proteins FlhA, FlhB, FliP, and FliR to be within the flagellar basal
body [4–6]. It has been demonstrated that the hook-capping
protein (FlgD) and hook protein (FlgE) required all of the proteins
of the secretion apparatus for their export [7].
A detailed picture of the workings of the secretion apparatus is
gradually being elucidated [8,9]. It has been demonstrated that the
secretion apparatus harnesses the proton motive force to drive
export of the external flagellar components [10,11]. FlhA and
FlhB, the two largest membrane proteins of the flagellar secretion
apparatus, which both have predominant C-terminal cytoplasmic
domains have been most characterized. The crystal structures of
the cytoplasmic domains of FlhA from Salmonella and Helicobacter
pylori, and the crystal structure of the cytoplasmic domain of the
type III secretion system apparatus paralogue InvA from Salmonella
have recently been solved [12–14]. Also, several crystal structures
of the cytoplasmic domains of paralogues of FlhB found in
virulence-associated needles from enteric bacteria have recently
been described [15–17].
The cytoplasmic domains of FlhA and FlhB form a docking
platform for FliH, FliI, and FliJ. The cytoplasmic domain of FlhA
has been shown to bind the FliH, FliI, and FliJ proteins, and it is
also thought to be directly involved in the translocation of the
export substrates into the central channel of the growing flagellar
structure [18–22]. The cytoplasmic domain of FlhB has been
shown to undergo autocleavage associated with interaction with
FliK, which switches specificity of export of rod/hook-like
substrates to filament-type substrates [23–29]. The N-terminal
transmembrane region of FlhA has been implicated to interact
with the surrounding MS ring, from studies involving the isolation
of extragenic suppressor mutations [5].
Less is known about the functional role of the FliO, FliP, FliQ,
and FliR proteins in the secretion complex, though the protein
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33]. FliP, FliQ, and FliR are very hydrophobic and were predicted
to be predominantly located within the cytoplasmic membrane.
However, FliO was predicted to be a bitopic membrane protein
with a predominant soluble domain. Intriguingly, FliO shows the
least conservation among the secretion system apparatus mem-
brane proteins, even being absent from some systems [3,34,35].
Notably, the type III secretion system apparatus of the virulence-
associated needles of Salmonella serovar Typhimurium lack a FliO
homologue, as does the flagellum of the ancient hyper-thermo-
philic bacterium Aquifex aeolicus [3,35]. Since the FliO protein is
not necessary for some systems it suggests that the FliO protein
might function as an accessory protein and have a specialized role
where it is present. We have undertaken a mutational analysis of
FliO described herein, to determine whether or not it is essential
for flagellar assembly, which parts of the protein are important, its
orientation in the membrane, and possible interaction partners to
help understand its function.
Results
Incubation of a DfliO mutant in motility agar gave rise to
pseudorevertants containing bypass mutations in fliP
We first sought to characterize the FliO protein through
mutagenesis to investigate its function. To provide a genetic
background for complementation studies, a DfliO mutant was
engineered from the wild-type strain SJW1103. We found that the
DfliO mutant, CB186, was not completely non-motile, and
displayed a weakly motile phenotype after several hours in
motility agar. Surprisingly, pseudorevertants arose from this strain
with enhanced motility after about 42 hours extended incubation
(Figure 1A). In comparison strain CB184, which encodes a non-
polar D(fliO-fliP) deletion was completely non-motile (Figure 1B).
Four motile pseudorevertants from CB186 were purified, and the
two most motile were characterized further. These two strains
were designated CB191 and CB227.
To screen for the bypass mutations the genomic DNA of CB191
and CB227 was isolated and the flhA, flhB, fliO, fliP, fliQ, and fliR
genes were sequenced along with the fliF gene encoding the MS
ring, which surrounds the secretion apparatus in the membrane.
These genes were considered the most likely to contain suppressor
mutations. Each pseudorevertant contained a point mutation in
the fliP gene only. CB191 encoded an R143H mutation in FliP,
and CB227 encoded an F190L mutation in FliP.
To investigate the physiological effects of the extragenic bypass
mutations in fliP, engineered strains were constructed from
SJW1103 using l-Red genetic engineering (Figure 1C). Engi-
neered mutants encoding fliP(R143H) or fliP(F190L) mutations
only showed the same motility phenotype as SJW1103. Moreover,
an engineered mutant encoding DfliO fliP(F190L) was equally as
motile as CB227, which confirmed that the fliP(F190L) mutation
was responsible for the extragenic suppression of the fliO deletion
in strain CB227. However, an engineered strain encoding DfliO
fliP(R143H) was not as motile as CB191. This appeared to suggest
that the fliP(R143H) mutation was not the suppressor mutation
responsible for the improved motility in pseudorevertant strain
CB191. However, the engineered DfliO fliP(R143H) mutant gave
rise to pseudorevertants with enhanced motility after a much
shorter incubation time of 26 hours in motility agar in comparison
to a DfliO mutant, which took at least 42 hours (Figure 1D).
Therefore, in strain CB191 an additional bypass mutation
must be encoded along with fliP(R143H) to overcome the DfliO
deletion.
The FliO N-terminus is in the periplasm and its C-
terminus is in the cytoplasm
The above results suggested that FliO is regulating FliP so we
decided to characterize the FliO protein further to determine how
this might occur. Prior to this study the membrane topology of
FliO was unknown, so we started by determining the topology of
FliO. We used various prediction programs for the determination
of the topology of transmembrane proteins, and the majority
suggested that the 125-residue FliO protein is bitopic with a short
N-terminal periplasmic domain from residues 1 to 16–22, a
transmembrane region between residues 17–23 to 39–43, and a
large C-terminal cytoplasmic domain from residues 40–44 to 125
(Table S1).
To experimentally determine the membrane topology of FliO
we constructed plasmids to express chimeric gene fusions of the
phoA gene encoding the mature form of alkaline phosphatase, at
three specific points into the fliO gene. The mature form of
alkaline phosphatase is only active when found in the periplasm,
and its use is well established to determine membrane topology of
transmembrane proteins [36–38]. The entire amino acid
sequence of FliO was present in fusion product; and alkaline
phosphatase was encoded between residues 6 and 7, 100 and 101,
or 115 and 116 of FliO (Figure 2A). These fusion sites were
permissive for motility (data not shown). Immunoblotting using
anti-alkaline phosphatase antibody against whole cell lysates of
cells expressing the fusions, and the lysates fractioned into
insoluble membrane pellet fractions and soluble supernatant
fractions demonstrated that the three FliO/PhoA chimeras were
expressed stably and mainly partitioned with the insoluble
membrane pellet fraction (Figure 2B). To detect expression of
alkaline phosphatase, cells expressing the plasmid encoded
fusions were inoculated onto L-agar plates containing 40 mg
ml
21 5-Bromo-4-chloro-3-indoyl phosphate (Figure 2C). The
phoN gene was deleted from the chromosome of the strains used in
this experiment, to reduce background phosphatase expression.
Alkaline phosphatase activity was detectable only with the FliO1–
6::PhoA22–471::FliO7–125 fusion. These fusions were next genet-
ically engineered onto the chromosome of Salmonella.A l k a l i n e
phosphatase assays were performed, and higher phosphatase
Author Summary
The propeller-like flagella, which some bacteria use to
swim, possess a specialized secretion apparatus, which is
imbedded in the cell membrane for their formation. The
components are highly conserved among flagella systems
and also to the Type III secretion apparatus used by some
bacteria in conjunction with virulence-associated needle
complexes. The ubiquity of these secretion apparatuses
and their function as intricate nanomachines has made
them fascinating for biologists. The most studied flagellar
system is that of Salmonella enterica, which consists of 6
integral membrane proteins: FlhA, FlhB, FliO, FliP, FliQ, and
FliR. Among these proteins, FliO shows a sporadic
distribution in bacteria, and its function is unknown,
suggesting it might have a specialized role to play where it
is present. In this study, we show that FliO has an
important role in maintaining stability of FliP, which is a
highly conserved member of the secretion apparatus. We
have characterized the important regions of FliO through
mutagenesis. We have shown that it is possible to bypass
the effect of not producing the FliO protein, by encoding
mutations within FliP or by overexpressing the cytoplasmic
domain of FliO only.
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fusion, compared to the other chimeras, whether it was expressed
from the chromosome only or also expressed from plasmid
pTrc99A-FF4 (Table S2). This revealed that the N-terminus of
FliO is in the periplasm.
GFPuv has been reported to be useful as a reporter for
membrane protein topology in bacteria and it is fluorescent when
it is located in the cytoplasm [39]. We constructed plasmids to
encode chimeric gene fusions of the GFPuv gene between
residues 6 and 7, or 115 and 116 of FliO (Figure 2D). These
fusions were permissive for motility (data not shown). Immuno-
blotting using anti-GFP antibody against whole cell lysates of cells
expressing the fusions, and the lysates fractioned into insoluble
membrane pellet fractions and soluble supernatant fractions
demonstrated that the two FliO/GFPuv chimeras were expressed
stably and mainly partitioned with the insoluble membrane pellet
fraction. However, a difference in migration between the two
fusions is apparent, and the FliO1–115::GFPuv::FliO116–125 fusion
produced multiple bands (Figure 2E). The reason for this is not
clear. In previousstudies,multiple bands ofFliO were detected by
immunoblotting [32,33]. The authors could not conclusively
identify the source of the multiple bands, but speculated that the
N-terminus of FliO underwent proteolytic cleavage, which did
not appear to be physiologically important. We presume that the
chimeric fusions we have constructed are somehow affecting this
N-terminal modification of FliO. However, fluorescence was
detectable only with the FliO1–115::GFPuv::FliO116–125 fusion
(Figure 2F). This revealed that the C-terminus of FliO is in the
cytoplasm.
Mutational analysis of FliO reveals the cytoplasmic
domain of FliO is functionally important
Having defined the membrane topology of FliO, we next
sought to determine the functionally important regions of the
FliO protein by examining the ability of FliO proteins
truncated from the N-terminus or the C-terminus to rescue
the motility of a DfliO strain in motility agar. The truncated
proteins were expressed from plasmid pTrc99A-FF4 without
IPTG induction (Figure 3A). Immunoblotting using polyclonal
anti-FliO43–125-6xHis antibodies was performed first to confirm
expression of the proteins. Full-length FliO1–125,F l i O 22–125,
FliO43–125,F l i O 1–95,F l i O 1–105,a n dF l i O 1–115 were detected by
immunoblotting (Figure 3B). FliO1–125,F l i O 1–95, FliO1–105,a n d
FliO1–115 produced multiple bands of FliO, while FliO22–125 and
FliO43–125 did not. As mentioned in the previous section, it was
suggested in a previous study that FliO is subject to N-terminal
cleavage or modification by an unknown mechanism and the
multiple bands presumably reflect this [33]. It was not possible to
detect FliO at physiological levels from whole-cell lysates of
SJW1103, therefore, the proteins produced from pTrc99A-FF4
were detectable by immunoblotting, because they were being over-
expressed from this vector. It was not possible to detect FliO1–65,
FliO1–75, and FliO1–85 by immunoblotting, which could be due to
the specificity of the antibody or because these proteins were not
expressed. A FLAG-tag (N-MDYKDDDDK-C) was engineered at
the N-terminus of FliO1–125, FliO1–65,F l i O 1–75, and FliO1–85 to
attempt to detect protein expression by immunoblotting using
ANTI-FLAG antibody. However, only FLAG-tagged FliO1–125
was detectable by immunoblotting, so if FLAG-tagged FliO1–65,
FliO1–75 and FliO1–85 were produced expression was much lower
(data not shown).
Expression of FliO22–125 or FliO43–125, which are truncated at
the N-terminus, was able to complement the DfliO strain CB186
(Figure 3C). FliO22–125 encoded a methionine at position 22 in
place of a natural valine and this truncation was included since it
has been shown to be functional in previous studies [31,33].
Surprisingly, FliO43–125 could complement, as this corresponds to
the cytoplasmic domain of FliO, and is without the transmembrane
domain. Overexpression was necessary for the cytoplasmic domain
to rescue motility of CB186, since FliO43–125 was not able to
complement when expressed from the T7 promoter of plasmid
pET-22b(+), without IPTG induction, while full-length FliO1–125
was able to rescue motility when expressed from this vector (data
Figure 1. Isolation of pseudorevertants containing bypass mutations in fliP from a poorly motile DfliO mutant. (A) Incubation of a DfliO
strain, CB186, in soft-tryptone motility agar after 42 hours. The strain is extremely poorly motile, but outgrowths of motile pseudorevertants can be
observed as motility halos, indicated by white arrows. (B) Incubation of a non-motile D(fliO-fliP) strain, CB184, in motility agar after 42 hours. (C)
Comparison of motility of pseudorevertants, purified from CB186, to engineered strains after 6 hours in motility agar: WT, wild-type is strain SJW1103;
CB191 is a pseudorevertant strain and encodes DfliO fliP(R143H); CB227 is a pseudorevertant strain and encodes DfliO fliP(F190L). Other strains were
engineered mutants constructed from SJW1103 by l-Red genetic engineering. (D) Formation of motile pseudorevertants by the DfliO fliP(R143H )
engineered mutant after only 26 hours. All plates were incubated at 30uC.
doi:10.1371/journal.pgen.1001143.g001
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from the C-terminus were able to restore almost full motility to
CB186, so the C-terminal 30 amino acids of FliO are not essential.
In comparison, FliO1–75 and FliO1–85 could only weakly restore
motility to CB186, while FliO1–65 could not (Figure 3C).
Residue leucine 91 of the cytoplasmic domain of FliO is
important for function
N-terminal and C-terminal truncation analysis of FliO have
defined residues 22–95 as the most important. Moreover,
overexpression of the cytoplasmic domain of FliO could rescue
Figure 2. The FliO N-terminus is in the periplasm and its C-terminus is in the cytoplasm. (A) Schematic overview of chimeric fusions of
alkaline phosphatase within FliO. (B) Immunoblotting using anti-alkaline phosphatase antibody against cell fractions of strains expressing FliO/
alkaline phosphatase chimeras (60.3 kDa): C, whole cells; P, insoluble membrane pellet fraction; S, soluble supernatant fraction. (C) Growth of strains
expressing FliO/alkaline phosphatase chimeras on L-agar plates containing 40 mgm l
21 5-Bromo-4-chloro-3-indoyl phosphate at 37uC. All strains
contained a DphoN301 deletion. (D) Schematic overview of chimeric fusions of GFPuv within FliO. (E) Immunoblotting using anti-GFP antibody
against cell fractions of strains expressing FliO/GFPuv chimeras (39.9 kDa). (F) Growth of strains expressing FliO/GFPuv chimeras on L-agar plates at
30uC. All fusions were expressed from plasmid pTrc99A-FF4 without IPTG induction.
doi:10.1371/journal.pgen.1001143.g002
Mutational and Topological Analysis of FliO
PLoS Genetics | www.plosgenetics.org 4 September 2010 | Volume 6 | Issue 9 | e1001143Figure 3. Complementation of a DfliO strain by FliO truncated at the N-terminus or C-terminus. (A) Schematic overview of FliO deletion
mutants with the corresponding molecular weight of the protein. (B) Immunoblotting using polyclonal anti-FliO43-125-6xHis antibody against 10–20%
gradient SDS-PAGE separated whole cell lysates of the wild-type strain, SJW1103, containing empty pTrc99A-FF4 vector, or a DfliO mutant (strain
CB186) containing empty vector, or strain CB186 expressing the truncated FliO proteins from plasmid pTrc99A-FF4 (without IPTG induction). (C)
Complementation of strain CB186 by the truncated FliO proteins expressed from plasmid pTrc99A-FF4. SJW1103, containing empty pTrc99A-FF4
vector, was included for comparison. Soft-tryptone motility agar inoculated with the strains was incubated for 6 hours at 30uC.
doi:10.1371/journal.pgen.1001143.g003
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functionally important. We next undertook a site-directed
mutagenesis study of the cytoplasmic domain to identify important
residues to confirm it is functionally important. We aligned the
FliO proteins from closely related Gammaproteobacteria, to identify
conserved residues. There was considerable sequence variation,
but several conserved amino acids between residues 43–95 of the
cytoplasmic domain of FliO could be identified (Figure S1). To
screen for the important residues, we performed site-directed
mutagenesis for full-length FliO creating point substitutions for
alanine or point deletions at the following positions: G64, R68,
V74, G82, T84, L91, and L94. Plasmids encoding these mutations
were then examined for their ability to rescue motility of the DfliO
mutant, CB186, in soft-tryptone motility agar. FliO(D91) was
identified to cause a reduction in motility (data not shown).
Immunoblotting using polyclonal anti-FliO43–125-6xHis antibodies
demonstrated that FliO(L91A) and FliO(D91) could be expressed
stably (Figure 4A). Strains containing the fliO(L91A)o rfliO(DL91)
mutant alleles on the chromosome were engineered, and both
strains were dramatically less motile (Figure 4B). Residue leucine
91 of the cytoplasmic domain is therefore very important for the
function of FliO.
Circular dichroism (CD) spectroscopy analysis of the
cytoplasmic domain of FliO
We have revealed that the cytoplasmic domain of FliO is
functionally important, so we next studied this domain by circular
dichroism (CD) spectroscopy to see whether it is structured. Based
on secondary structure prediction the cytoplasmic domain of FliO
should contain four beta-strands and one alpha-helix (Figure 5A).
FliO43–125-Ala was purified using a C-terminal intein fusion tag.
An additional alanine residue at the C-terminus was added to
facilitate removal of the intein-tag. After cleavage of the intein
fusion tag and purification FliO43–125-Ala was studied using CD
spectroscopy. From the shape of the spectra, the structure of
FliO43–125-Ala apparently consists mostly of random coil and some
b-structure (Figure 5B). Melting of FliO43–125-Ala was irreversible
due to aggregation, this often happens with b-structural proteins
[40]. Then FliO43–125-Ala was titrated with urea and no two-state
transition was observed. From these data we conclude that this
peptide is disordered and its structure is a mixture of random coil
and beta-sheet.
Full-length FliO increases FliP expression
We have shown that bypass mutations in fliP can rescue motility
for cells deleted for the fliO gene. We have also shown through
mutagenesis that the most important residues of FliO are between
amino acids 22 to 95, and the cytoplasmic domain alone has
functionality. To further characterize the apparent regulation of
FliP by FliO, we investigated the effect of FliO co-expression on
the synthesis of plasmid expressed FLAG-tagged FliP in the D(fliO-
fliP) strain CB184. A FLAG-tag epitope (N-DYKDDDDK-C) was
encoded between codons 22 and 23 of fliP. The FLAG-tag was
added to enable detection of FliP expression by immunoblotting
with ANTI-FLAG antibody. After cleavage of the N-terminal
signal peptide of FliP, which occurs between residues 21 and 22,
the FLAG-tag would be encoded immediately after the glutamine
residue. FLAG-tagged FliP was expressed alone, or co-expressed
with full-length FliO, or co-expressed with the cytoplasmic domain
of FliO. FLAG-tagged FliP expression levels were not improved if
the R143H or F190L bypass mutations were encoded (data not
shown). Expression of full-length FliO or the cytoplasmic domain
FliO43–125, was detected from the co-expression vectors by
immunoblotting with polyclonal anti-FliO43–125-6xHis antibody
(Figure 6A). Expression of FLAG-tagged FliP was dramatically
improved when full-length FliO was co-expressed. However,
Figure 4. Residue leucine 91 is important for FliO function. (A)
Immunoblotting using polyclonal anti-FliO43–125-6xHis antibody against
10–20% gradient SDS-PAGE separated whole cell lysates of a DfliO
mutant (strain CB186) containing empty vector, or strain CB186
expressing FliO or mutated FliO proteins (approximately 13 kDa) from
plasmid pTrc99A-FF4 without IPTG induction. (B) Incubation of the wild-
type strain SJW1103 or genetically engineered mutants in soft-tryptone
motility agar for 6 hours at 30uC.
doi:10.1371/journal.pgen.1001143.g004
Figure 5. Circular Dichroism (CD) Spectroscopy analysis of the
cytoplasmic domain of FliO. (A) Predicted regions of secondary
structure of FliO43–125: Bold, regions with predicted b-structure; Italic,
regions with predicted a-helix. (B) CD spectrum (mean residue ellipticity
vs wavelength) of FliO43–125-Ala in 20 mM Na/K phosphate, pH 6.2;
100 mM NaCl.
doi:10.1371/journal.pgen.1001143.g005
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the cytoplasmic domain of FliO was co-expressed (Figure 6B).
Overexpression of the cytoplasmic domain of FliO in
strains deleted for fliO and expressing bypass mutations
in fliP further rescues motility
We have revealed that full-length FliO can stabilize FliP
expression, while the cytoplasmic domain of FliO cannot. We have
also shown that overexpression of the cytoplasmic domain of FliO,
FliO43–125, can rescue motility of cells with the fliO gene deleted.
We have further shown that extragenic bypass mutations within
the fliP gene can also partially restore motility to the DfliO mutant.
We next demonstrated that expression of FliO43–125 from
pTrc99A-FF4 could further rescue motility to near wild-type
levels for engineered strains encoding the DfliO fliP(R143H)o r
DfliO fliP(F190L) mutations (Figure 7).
Discussion
In this study, we have undertaken a detailed molecular analysis
of the FliO secretion apparatus protein and its role in flagella
assembly. FliO was previously considered to be necessary for
secretion in Salmonella [7]. However, we have demonstrated using
an engineered non-polar DfliO mutant that while deletion of the
fliO gene leads to a dramatic reduction in motility, cells are not
completely non-motile. Moreover, it was possible to readily isolate
pseudorevertants containing bypass mutations in fliP, which help
to rescue motility. The FliO protein is not conserved in all type III
secretion systems, yet in this study we have shown that it has an
important functional role in regulating FliP stability, which is a
highly conserved member of the secretion system membrane
proteins.
We have also shown that FliO has a predominant C-terminal
cytoplasmic domain, which is in contrast to the previously
predicted membrane topology of FliO, which suggested that the
C-terminus is in the periplasm [32]. Coexpression of the
cytoplasmic domain of FliO with FliP did not increase FliP
expression levels, while coexpression of full-length FliO with FliP
improved FliP expression levels. This suggests that the trans-
membrane region of FliO stabilizes FliP, since the periplasmic
domain of FliO appears to be non-essential from our truncation
analyses. However, we have shown that the cytoplasmic domain
represents a functional unit beyond merely being required for
FliO membrane insertion, since overexpression of the cytoplas-
mic domain only of FliO could improve motility of cells encoding
a fliO gene deletion, with or without additional bypass mutations
in fliP.
In Buchnera sp. APS a gene fusion of fliO and fliP exists [41]. This
suggests along with the results presented here that FliO and FliP
probably also interact in Salmonella. This is important because FliP
has been demonstrated to be located within the flagellar basal
Figure 6. FliO increases expression of FliP. FLAG-tagged FliP (25.4 kDa) was expressed alone, or co-expressed with FliO (13.1 kDa), or co-
expressed with the cytoplasmic domain of FliO, FliO43–125 (8.8 kDa), from plasmid pTrc99A-FF4 without IPTG induction. Whole cell lysates were
separated by 10–20% gradient SDS-PAGE, prior to immunoblotting. (A) Immunoblotting with polyclonal anti-FliO43–125-6xHis antibody. (B)
Immunoblotting with ANTI-FLAG antibody. Results are representative of the experiment performed in triplicate.
doi:10.1371/journal.pgen.1001143.g006
Figure 7. Rescue of motility by overexpression of the
cytoplasmic domain of FliO. SJW1103 is a wild-type strain. Strains
genetically engineered from SJW1103 contained a fliO gene deletion
with or without bypass mutations in the gene for fliP. The cytoplasmic
domain of FliO, FliO43–125, was expressed from plasmid pTrc99A-FF4
without IPTG induction. Soft-tryptone motility agar inoculated with the
strains was incubated for 6 hours at 30uC.
doi:10.1371/journal.pgen.1001143.g007
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the 2
nd and 3
rd loops connected by a large (approximately 80-
residue) periplasmic domain (Figure S2). The nature of the bypass
mutations described here in the primary sequence of FliP, appear
to be remarkably subtle. The bypass mutation F190L is located in
predicted transmembrane loop 3, and was physiologically relevant
by itself at improving motility in a fliO deletion background.
However, the F190L mutation did not improve levels of FliP
suggesting that the mutation is a gain-of-function mutation that
overcomes the supporting role of FliO through a different
mechanism. The FliP(R143H) mutation alone was not sufficient
to greatly improve motility, rather it somehow increases the
spectrum of bypass mutations permissible for rescuing motility of a
fliO deletion mutant. Since arginine 143 is located in the
periplasm, mutations might occur in other proteins, which interact
with this domain. We are presently mapping the additional bypass
mutation in strain CB191, which exists together with the
fliP(R143H) bypass mutation. FliP(R143H) and FliP(F190L) do
not correspond to residues found at the same position for the A.
aeolicus FliP orthologue or the Salmonella serovar Typhimurium FliP
needle paralogues, SsaR and SpaP, which are all found in type III
secretion systems without a FliO homologue (Figure S2). So these
FliP homologues might consist of amino acid residues that increase
their stability, or they are part of secretion systems, which do not
require the supporting role(s) that FliO plays in the Salmonella
system.
The most highly conserved part of the FliO protein is between
residues 22 to 95. This is consistent with the results of the
truncation analysis, which showed that the periplasmic domain
and C-terminal 30 amino acid residues are non-essential.
However, mutating residue leucine 91 of the cytoplasmic domain
severely disrupted FliO function. Furthermore, overexpression of
the cytoplasmic domain of FliO can partially rescue motility of a
DfliO mutant, demonstrating functionality of this domain.
Presumably, overexpression of the cytoplasmic domain of FliO
overcomes the localization defect of not producing the trans-
membrane domain, and so overexpression enables the cytoplas-
mic domain to find its interaction partner(s). However, it is
intriguing to know how this domain can function without being
anchored to the membrane, since this suggests it might function
as bridging domain to maintain protein complex stability, rather
than having a catalytic role in protein translocation? Using
circular dichroism spectroscopy we showed that the structure of
the cytoplasmic domain FliO43–125-Ala is a mixture of beta-sheet
and random coil. We assume that the FliO cytoplasmic domain
becomes structured while interacting with its binding partners
similar to binding domains of many other proteins that acquire
tertiary structure upon binding to their partners, such as in
flagellin/flagellin or tropomodulin/tropomyosin interactions
[42,43].
Materials and Methods
Bacterial strains and plasmids
The bacterial strains and plasmids used in this study are listed
(Table S3 and Table S4, respectively). Soft-tryptone motility agar,
0.35% (w/v), was used in motility assays [44]. Motility agar plates
were maintained at 30uC, and inoculated from colonies from fresh
overnight transformations. Ampicillin was used in media at 100 mg
ml
21 for Salmonella strains and 50 mgm l
21 for E. coli strains.
Kanamycin was used at 50 mgm l
21, tetracycline at 15 mgm l
21,
chloramphenicol at 34 mgm l
21, and 5-Bromo-4-chloro-3-indoyl
phosphate at 40 mgm l
21, where applicable. All chemicals were
obtained from Sigma-Aldrich or Wako, Japan.
Genetic engineering procedures
The oligonucleotides used in the strain and plasmid construc-
tions are listed (Table S5 and Table S6, respectively). To construct
chromosomal gene deletions and replacements l-Red-based
recombination was used employing plasmid pKD46 [45,46]. To
construct chromosomal gene deletions a kanamycin-resistance
cassette was obtained from plasmid pKD13 by PCR, flanked with
approximately 40-bp ends homologous to the target site. After
chromosomal integration the kanamycin resistance cassette was
excised using plasmid pCP20 so that the ‘scar’, which remains
afterwards within the target gene(s) was encoded as an in-frame
short polypeptide for the non-polar deletions, or the ‘scar’ was in
the reverse orientation for the DphoN301 allele. The DfliO22252
deletion encodes the first 5 residues, and the final 8 residues of
FliO, linked by 27-amino acid residues from an internal ‘scar’
sequence within the fliO gene. The D(fliO-fliP)22251 deletion
encodes the first 5 residues of FliO and the last 5 residues of FliP,
joined by 28 residues encoded by a scar sequence.
To construct chromosomal gene replacements a tetRA tetracy-
cline-resistance cassette was obtained by PCR from SGSC3718
genomic DNA flanked by approximately 40-bp ends homologous
to the target site. After chromosomal integration, it was possible to
counter-select against the tetracycline-resistance cassette on
medium containing fusaric acid. Then the targeted region of the
chromosome was replaced using PCR-amplified DNA containing
homologous-ends. To create fliO::phoA or fliO::gfpuv chimeric gene
fusions in plasmid pTSO17, which carries the fliO gene, it was first
linearized at the desired point by non-strand displacing PCR.
Then either a phoA gene PCR product obtained from E. coli K-12
MG1655 genomic DNA or a GFPuv gene PCR product obtained
from plasmid pGFPuv (Clontech), which was flanked by 15-bp fliO
homologous ends, was inserted by the homologous recombination-
based In-fusion PCR cloning procedure (Clontech). Site-directed
mutagenesis was performed using the QuickChange Lightning
Site-Directed Mutagenesis Kit (Stratagene).
Purification of FliO43–125-Ala and FliO43–125-6xHis
FliO43–125-Ala was purified using a C-terminal intein tag
encoded by a pTXB1-based expression plasmid, according to
manufacturer’s instructions (New England Biolabs). BL21 Star
containing plasmid pTSO133 was cultivated. The cell pellet from
5-L culture was suspended in 200-ml buffer consisting of 40 mM
Tris-HCl (pH 8.0), 1 M NaCl, 2 mM EDTA, and 20% glycerol,
and lysed by sonication. Insoluble proteins and cell debris were
collected by low-speed centrifugation and suspended in 100-ml
buffer containing 40 mM Tris-HCl (pH 8.0), 0.5 M NaCl, and
8 M urea. The suspension was incubated with stirring at room
temperature for 3 hours. Insoluble material was removed by
centrifugation. After centrifugation, the supernatant was diluted
four times with washing buffer consisting of 40 mM Tris-HCl
(pH 8.0), 0.5 M NaCl, and 1 M urea, and loaded onto a chitin
bead column equilibrated with washing buffer (the column volume
was 30-ml). The column was washed with 200-ml of washing
buffer, and then with 100-ml of washing buffer containing 0.1 M
DTT. After that the column was incubated at room temperature
for about 20 hours. FliO43–125-Ala was eluted from the chitin
column with 50-ml of washing buffer and further purified by gel-
filtration on a HiLoad Superdex-75 gel filtration column (GE
healthcare) equilibrated with the same buffer. Fractions containing
pure FliO43–125-Ala were pooled together, and the protein was
transferred by dialysis in 20 mM Na/K phosphate (pH 6.2), and
100 mM NaCl. FliO43–125-6xHis was purified according to
standard procedures, using nickel affinity chromatography under
denaturing conditions after expression from plasmid pESO221.
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Immunoblotting was performed similar to a previously
described method [25]. For immunoblotting of whole cell lysates,
colonies of Salmonella serovar Typhimurium containing the desired
plasmid, from an overnight transformation, were inoculated into
5-ml LB with antibiotic and grown with shaking for 6 hours at
37uC. Cells were harvested by centrifugation at 16,100-g for 5
minutes, and the pellets were re-suspended in SDS-PAGE loading
buffer (100 mM Tris-HCl, pH 6.8, 2% SDS, 1 mM b-mercapto-
ethanol, 7 M urea, and 0.1% bromophenol blue) and incubated at
95uC for 15 minutes. An equivalent amount of each whole cell
lysate was separated by SDS PAGE and proteins were either
detected by staining with Coomassie brilliant blue or transferred to
PVDF membranes. Immunoblotting was performed using the
anti-rabbit WesternBreeze Chromogenic Kit (Invitrogen), accord-
ing to manufacturer’s instructions. The following antibodies and
dilutions were used: anti-alkaline phosphatase (Rockland, PA,
USA), 1:20,000 dilution; anti-GFP (Clontech), 1:5,000 dilution;
ANTI-FLAG (Sigma-Aldrich), 1:5,000 dilution; and polyclonal
anti-FliO43–125-6xHis antibody, 1:10,000 dilution.
Cell fractionation
Cells were separated into the insoluble membrane pellet fraction
and soluble supernatant fraction after lysis similar to a previously
described method [47]. Briefly, from overnight transformations,
colonies of Salmonella serovar Typhimurium containing the desired
plasmid were inoculated into 50-ml LB with antibiotic and grown
with shaking for 7 hours at 37uC. Cells were harvested by
centrifugation at 6000-g for 10 minutes, and the pellets were re-
suspended in 11-ml 50 mM Tris-HCl (pH 8.0), 10 mM MgCl2,
and 440-ml2 5 6 EDTA-free protease inhibitor cocktail (Roche).
Cell pellets were lysed by sonication at 25% power for 5 cycles of
one minute each. After incubation at room temperature for 30
minutes unlysed cell debris was removed by low-speed centrifu-
gation at 10,000-g for 10 minutes. The insoluble membrane pellet
was obtained by high-speed centrifugation at 100,000-g for 1 hour
and resuspended in 1-ml 50 mM Tris-HCl (pH 8.0), and 10 mM
MgCl2. One-ml was added to 5-ml SDS-PAGE loading buffer for
electrophoresis. The supernatant was further clarified by centri-
fugation at 100,000-g for 1 hour and 10-ml was added to 5-ml SDS-
PAGE loading buffer for electrophoresis.
Observation of GFPuv fluorescence and measurement of
alkaline phosphatase activity
Expression of FliO/GFPuv chimeras was detected for strains
inoculated onto L-agar plates containing the appropriate antibi-
otic, after 4 days incubation at 30uC, using a transilluminator set
at 365 nm UV. Alkaline phosphatase assays are detailed in
Text S1.
Circular Dichroism (CD) Spectroscopy
CD spectra of FliO43–125-Ala was measured using an Aviv
model 400 spectropolarimeter (Lakewood, NJ) in 0.1 cm cuvettes
at 0uC in 20 mM Na/K phosphate, pH 6.2; 100 mM NaCl. Urea
titration ellipticity at 220 nm was measured for samples in 0, 1, 2,
3, 4, 5, 6, 7 and 8 M urea at 10uC.
Bioinformatics
Protein secondary structure prediction was performed using
Jpred 3 [48]. Programs used to align protein sequences, and
programs used to predict membrane protein-membrane topology
are detailed in Text S1.
Supporting Information
Figure S1 Alignment and predicted membrane topologies of FliO
proteins from Gammaproteobacteria.S A L T Y=Salmonella enterica
serovar Typhimurium; ECOLI = Escherichia coli K-12; ERWTA
= Erwinia tasmaniensis; YEREN = Yersinia enterocolitica;X A N C A=
Xanthomonas campestris;V I B C H=Vibrio cholerae; and PSEAE =
Pseudomonas aeruginosa. We have shown for Salmonella serovar
Typhimurium FliO that the underlined residues in bold type could
be truncated from the N-terminus or the C-terminus, and FliO still
remained partially functional. We also identified residue leucine 91
(black bold-type) is important for the function of full-length Salmonella
serovar Typhimurium FliO. The percentage score of the FliO
homologues with Salmonella serovar Typhimurium FliO is indicated.
Found at: doi:10.1371/journal.pgen.1001143.s001 (0.03 MB
PDF)
Figure S2 Alignment and predicted membrane topologies of
FliP, and FliP homologues. Salmonella enterica serovar Typhimurium
FliP, the Aquifex aeolicus FliP orthologue, and the Salmonella serovar
Typhimurium FliP paralogues, SpaP and SsaR were aligned.
SALTY = Salmonella serovar Typhimurium, and AQUAE =A.
aeolicus. A. aeolicus FliP, and SpaP and SsaR are found in Type III
secretion systems without a FliO homologue. In this study, it was
shown that bypass mutations in Salmonella serovar Typhimurium
FliP corresponding to R143H and F190L, could partially rescue
motility of a fliO deletion mutant. Residues aligned with arginine
143 and phenylalanine 190 of Salmonella serovar Typhimurium
FliP are indicated in dark red bold type. The percentage score of
the homologues with Salmonella serovar Typhimurium FliP is
indicated.
Found at: doi:10.1371/journal.pgen.1001143.s002 (0.03 MB
PDF)
Table S1 Prediction of FliO transmembrane topology.
Found at: doi:10.1371/journal.pgen.1001143.s003 (0.05 MB
DOC)
Table S2 Alkaline phosphatase activity of Salmonella enterica
serovar Typhimurium expressing chimeric fusions of alkaline
phosphatase within FliO.
Found at: doi:10.1371/journal.pgen.1001143.s004 (0.03 MB
DOC)
Table S3 Strains used in this study.
Found at: doi:10.1371/journal.pgen.1001143.s005 (0.06 MB
DOC)
Table S4 Plasmids used in this study.
Found at: doi:10.1371/journal.pgen.1001143.s006 (0.06 MB
DOC)
Table S5 Oligonucleotides used in strain constructions.
Found at: doi:10.1371/journal.pgen.1001143.s007 (0.06 MB
DOC)
Table S6 Oligonucleotides used in plasmid constructions.
Found at: doi:10.1371/journal.pgen.1001143.s008 (0.12 MB
DOC)
Text S1 Supplementary materials and methods.
Found at: doi:10.1371/journal.pgen.1001143.s009 (0.03 MB
DOC)
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